Global Eucommia Extract Market Overview:
Eucommia extract, derived from the bark and leaves of the Eucommia ulmoides tree, is a natural supplement boasting a rich history in Traditional Chinese Medicine (TCM) and an emerging presence in Western wellness circles. Packed with bioactive compounds, it's touted for its diverse potential benefits, ranging from improved cardiovascular health to enhanced athletic performance. Eucommia extract is also used in Russia for people who have high blood pressure without any side effects.
As per latest study released by AMA Research, the Global Eucommia Extract market is expected to see growth rate of 7.0%Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2018-2023 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Rising Health Conscious Peoples
Market Growth Drivers:
Growing Applications of Eucommia Extract to Treat High Blood Pressure and Diabetes
Challenges:
Lack of Awareness among Population
Restraints:
Side Effects Related to the Consumption of Eucommia Extract such as headache, dizziness, edema, and others
Opportunities:
Surging Demand from Food Industry can create Opportunity for the Eucommia Extract Market Demand
Competitive Landscape:
Key players are adopting numerous strategies to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnerships to adopt certain technologies, and acquiring small players to finish the competition in the future. As well as investing money in the R&D sector to make technical upgrades to the product.
Some of the key players profiled in the report are Hunan Sunfull Bio-Tech Co., Ltd. (China), Kingherbs Limited (China), HEFEI JOYE IMPORT & EXPORT CO., LTD. (China), Xuancheng Quality Herb Co., Ltd. (China), Shaanxi Sinuote Biotech Co., Ltd. (China), Shanghai GREAF Biotech Co., Ltd. (China), Hunan Nutramax Inc. (China), XINGTAI XINGJIU NEW MATERIAL TECHNOLOGY CO., LTD. (China) and Changsha Heking Bio- Tech Co., Ltd. (China). Analyst at AMA Research see Chinese Vendors to retain maximum share of Global Eucommia Extract market by 2030. Considering Market by Form, the sub-segment i.e. Powder will boost the Eucommia Extract market. Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Eucommia Extract market. Considering Market by Color, the sub-segment i.e. Yellow will boost the Eucommia Extract market.
Latest Market Insights:
In July 2023, Nature's Way, a leading herbal supplement company, acquired Gaia Herbs, another major player in the natural products industry. This move could potentially strengthen the presence of Eucommia Extract products in the herbal supplement market.
In September 2023, NeuroVite launched a new supplement containing Eucommia Extract alongside other ingredients known to support brain health. This move could potentially strengthen the presence of Eucommia Extract products in the herbal supplement market.
The National Institutes of Health (NIH) warns that herbal products may be contaminated with toxic compounds, heavy metals, pesticides, or microorganisms. Manufacturing errors, in which one herb is mistakenly replaced with another, have also occurred.
What Can be Explored with the Eucommia Extract Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Eucommia Extract Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Eucommia Extract
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Eucommia Extract market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Eucommia Extract market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Eucommia Extract Manufacturers, Eucommia Extract Suppliers and Distributors, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.